‘What came first: the disorder, the cure, or the marketing campaign to sell both?
“You’re talking about a product that’s having a major impact on brain chemistry. Parents are very susceptible to this type of stuff.” –Roger Griggs, pharma exec who now objects to ad campaigns
In the case of medicating a generation of children who were said to be “unusually hyperactive,” the answer to that question is addressed by an in-depth investigation by the New York Times on Monday showing that the meteoric rise of diagnoses of attention deficit hyperactivity disorder (A.D.H.D.)—a trend that spawned a pharmaceutical gold rush over the last twenty years—was, in fact, fueled by an industry-led marketing campaign that targeted struggling children, worried parents, and an army of doctors willing to diagnose and prescribe.
And what’s worse? The deep-pocketed, pill-pushers are now looking to expand.’
Read more...
Advertisement
You have just read the article News for today's that category by title How Big Pharma Markets to and Profits from a ‘Can’t-Pay-Attention Nation’. You can bookmark this page with a URL https://news-these-days.blogspot.com/2013/12/how-big-pharma-markets-to-and-profits.html. Thank you!
Posted by: Anonymous
How Big Pharma Markets to and Profits from a ‘Can’t-Pay-Attention Nation’ Updated at :
2:26 AM
Wednesday, December 18, 2013
Post a Comment